BioSpace News Archive

Pharis Mohideen, M.D., is departing the company to pursue a career opportunity closer to his home in New Jersey, allowing him to spend more time with his family.

Net Proceeds to Fuel Hemp Research, Innovation and Scale-Up of GoodWheat™

EyePACS LLC surges past 750,000 patient encounters for diabetic telemedicine services

RAPT Therapeutics, Inc. announced that it secured an additional $37 million in an extension of its Series C financing.

New facility in Frederick, Colorado, to produce high-quality molecules with the potential to treat cancer and other diseases

Novigenix SA announced the appointment of Francois Martelet, M.D., to its Board of Directors as a non-executive director.

Agnès Pannier-Runacher, Secretary of State to the Minister of Economy and Finance to participate in the opening

Swedish Orphan Biovitrum AB announces that new research demonstrating the effects of emapalumab in patients with macrophage activation syndrome, a form of secondary haemophagocytic lymphohistiocytosis complicating systemic juvenile idiopathic arthritis, was presented at the European League Against Rheumatism/ Paediatric Rheumatology European Society Scientific Congress in Madrid.

Axonics Modulation Technologies, Inc. announced the U.S. Food & Drug Administration approved the use of full-body magnetic resonance imaging using 1.5 Tesla MRI scanners for clinical study patients implanted with the Axonics System.

Sage Therapeutics announced that the Company will present at the BMO Prescriptions for Success Healthcare Conference on Tuesday, June 25, 2019 at 8:40 a.m. EST in New York, NY.